In breast cancer, the TN subtype presents characteristics that make it more susceptible to immunotherapy, such as the increased infiltration of T lymphocytes and elevated levels of protein expression, such as PD-L1, in tumor cells and the immune system. This evidence concerns the gene CD274 and breast carcinoma.